MétaCan
Menu
← Back to cohort

Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH)

2013· article· en· W2259710024 on OpenAlexaff
Olivier Sitbon, Richard N. Channick, Marion Delcroix, Nazzareno Galiè, Hossein Ardeschir Ghofrani, Pavel Jansa, Franck‐Olivier Le Brun, Sanjay Mehta, Loı̈c Perchenet, Tomás Pulido, B.K.S. Sastry, Rogério Souza, Adam Torbicki, Lewis J. Rubin, Gérald Simonneau

Bibliographic record

VenueEuropean Respiratory Journal · 2013
Typearticle
Languageen
FieldMedicine
TopicPulmonary Hypertension Research and Treatments
Canadian institutionsVictoria HospitalLondon Health Sciences CentreWestern University
Fundersnot available
KeywordsMedicineTadalafilHemodynamicsPulmonary hypertensionPlaceboVascular resistanceCardiac indexInternal medicineCardiologySildenafilAnesthesiaCardiac outputPathology

Abstract

fetched live from OpenAlex

Macitentan's effect on haemodynamics in PAH patients was assessed at selected centres in the SERAPHIN study ( NCT00660179 ). 742 patients were randomised to placebo, macitentan 3 or 10mg q.d. Background phosphodiesterase-5 inhibitors and oral/inhaled prostanoids were allowed. 187 patients had right heart catheterisation at randomisation and Month 6. Placebo (n=68), macitentan 3mg (n=62) and 10mg (n=57) groups were well balanced for baseline haemodynamics with median pulmonary vascular resistance (PVR), 800, 785, 789 dyn·sec/cm 5 and cardiac index (CI) 2.49, 2.23, 2.47 L/min/m 2 . On average, all cardiopulmonary haemodynamics improved at Month 6 with macitentan and worsened with placebo. Subgroup analyses by background PAH therapy (naïve or treated) and baseline WHO FC I/II or III/IV showed that beneficial treatment effects with macitentan remained almost entirely significant for PVR and CI. Treatment effect on PVR (%)* and CI (L/min/m2) PVR CI Macitentan 3mg Macitentan 10mg Macitentan 3mg Macitentan 10mg All (n=187) -28.7 (-32.2,-19.2) -37.4 (-46.3,-26.6) 0.5 (0.3,0.8) 0.6 (0.4,0.9) Naïve (n=95) -19.9 (-34.2,0.8)** -40.3 (-52.0,-22.3) 0.4 (0.1,0.8) 0.6 (0.2,1.0) Treated (n=92) -34.4 (-45.6,-22.3) -33.3 (-45.6,-20.7) 0.6 (0.4,1.0) 0.6 (0.2,1.0) FC I/II (n=82) -35.2 (-49.2,-21.6) -46.0 (-57.2,-28.8) 0.5 (0.2,0.9) 0.7 (0.2,1.1) FC III/IV (n=105) -21.8 (-37.8,-9.2) -29.0 (-43.8,-16.6) 0.5 (0.3,0.9) 0.6 (0.3,1.0) Median (95% CL) placebo-corrected change from baseline. *Based on the log of Month 6/baseline values. All P<0.05 except** Macitentan improved cardiopulmonary haemodynamics in PAH patients with consistent improvements in PVR and CI irrespective of background PAH therapy and baseline WHO FC.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.277
Teacher spread0.257 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2013
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Respiratory Journal→Same topicPulmonary Hypertension Research and Treatments→French-language works237,207→